Tenofovir Disoproxil Fumarate Treatment for Pediatric Patients with Perinatally Acquired Chronic Hepatitis B

Journal Title: Gastro - Open Journal - Year 2015, Vol 1, Issue 4

Abstract

Objectives: Infection with Hepatitis B Virus (HBV) is an important cause of chronic liver disease in children. Perinatal transmission accounts for the majority of infections. We examined the effects of Tenofovir Disoproxil Fumarate (TDF) on pediatric patients with perinatally acquired Chronic Hepatitis B (CHB). Methods: We retrospectively analyzed the data on pediatric patients with perinatally acquired CHB treated with TDF over a 72-week period. Results: 55 cases were analyzed of which 26 were treated. Fourteen (54%) had immune active hepatitis and 12(46%) were in the immune tolerant phase. In both groups, no difference in inflammation or fibrosis was found on baseline liver biopsy. Mean HBV DNA level at baseline was 9 log10 copies/mL. Levels declined to 5.9 log10 copies/mL at 40 weeks of therapy and were undetectable in 19/26(73%) of the patients by week 72. Alanine aminotransferase (ALT) levels normalized by 32 weeks in the immune active hepatitis group. No breakthrough elevations were seen in either group. Overall, 11(42%) and 9(35%) of the patients had Hepatitis B e antigen (HBeAg) clearance and Hepatitis B e antibody (anti-HBe) seroconversion respectively by 72 weeks of treatment. Conclusion: TDF is an effective therapy in pediatric patients with perinatally acquired CHB in both immune active hepatitis and immune tolerant phase patients. Response to treatment did not seem to be affected by baseline ALT levels and liver histopathology findings.

Authors and Affiliations

Ricardo A. Arbizu

Keywords

Related Articles

A Double-Edged Sword and Swinging Pendulum: The Evolving Role of Percutaneous Endoscopic Gastrostomy Tubes in Patients with Advanced Dementia

Percutaneous Endoscopic Gastrostomy (PEG) tubes have been increasingly utilized in recent decades accompanying the rise in prevalence of disorders that require long-term nonoral enteral feeding such as Cerebrovascular ac...

Non-alcoholic Fatty Liver Disease and the Gut Microbiota: Exploring the Connection

As the gut microbiota continues to be implicated in an increasing number of disease processes, a plethora of new literature surrounding its complexity and role in the maintenance of intestinal homeostasis has become avai...

Duodenal Amyloidotic Tumor

This duodenal polypoid lesion was found during Esophago Gastro Duodenoscopy (EGDS) performed in a 77-year-old woman (Figure 1A). Our patient had already been diagnosed with multiple myeloma a few years earlier; although...

Coalescent Cyclical Vomiting: A Manifestation of Narcotic Bowel Syndrome?

This illustrative case suggests mechanisms that may contribute to disease progression and complications in adults with Cyclical Vomiting Syndrome (CVS). Symptoms initially followed a characteristic pattern in the context...

Capsule Endoscopy: Indications, Findings and Complications among Patients with Suspected Small Bowel Lesions

Background/Aims: Until a few years back, evaluation of small bowel pathology was unsatisfactory because of the inability to completely visualize the small bowel mucosa with the available endoscopic and radiological techn...

Download PDF file
  • EP ID EP555808
  • DOI 10.17140/GOJ-1-116
  • Views 157
  • Downloads 0

How To Cite

Ricardo A. Arbizu (2015). Tenofovir Disoproxil Fumarate Treatment for Pediatric Patients with Perinatally Acquired Chronic Hepatitis B. Gastro - Open Journal, 1(4), 94-99. https://europub.co.uk/articles/-A-555808